Gabriel Luciano
Chief Tech/Sci/R&D Officer bei CORVUS PHARMACEUTICALS, INC.
Profil
Gabriel Luciano is currently the Vice President-Clinical Operations at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Director-Clinical Operations at Pharmacyclics LLC from 2012 to 2017 and as the Senior Manager-Clinical Trail at Seagen Inc. from 2008 to 2011.
Mr. Luciano completed his undergraduate degree at the University of California, Santa Cruz.
Aktive Positionen von Gabriel Luciano
| Unternehmen | Position | Beginn |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Gabriel Luciano
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01.01.2017 |
| SEAGEN INC. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Gabriel Luciano
| University of California, Santa Cruz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
